Esperion Therapeutics, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 4, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 4, 2026 | Needham | downgrade | Buy → Hold | — | 50% |
| May 1, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Mar 13, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Mar 3, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Nov 25, 2025 | Piper Sandler | initiate | — → Overweight | $9 | 54% |
| Sep 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Jun 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| May 7, 2025 | Needham | maintain | Buy → Buy | $4 | 50% |
| Apr 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Apr 25, 2025 | Needham | reiterate | Buy → Buy | $5 | 50% |
| Apr 17, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $3 | 54% |
| Apr 8, 2025 | Needham | reiterate | Buy → Buy | $5 | 50% |
| Mar 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Mar 5, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $4 | 49% |
| Mar 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Feb 11, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $4 | 53% |
| Feb 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Jan 23, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $7 | 53% |
| Jan 23, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Jan 22, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Jan 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $0 | 44% |
| Dec 17, 2024 | Cantor Fitzgerald | initiate | — → Overweight | $8 | 50% |
| Dec 13, 2024 | Needham | reiterate | Buy → Buy | $6 | 50% |
| Dec 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Dec 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Dec 3, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $16 | 44% |
| Dec 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Nov 27, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Nov 19, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Nov 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Oct 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Aug 13, 2024 | Needham | maintain | Buy → Buy | $6 | 50% |
| Aug 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Jun 28, 2024 | Needham | reiterate | Buy → Buy | $8 | 50% |
| Jun 28, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Jun 20, 2024 | B of A Securities | downgrade | Neutral → Underperform | $2.5 | 53% |
| May 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| May 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| May 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| May 7, 2024 | Needham | reiterate | Buy → Buy | $8 | 50% |
| Apr 10, 2024 | Needham | reiterate | Buy → Buy | $8 | 50% |
| Mar 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Mar 25, 2024 | Needham | reiterate | Buy → Buy | $8 | 50% |
| Feb 28, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $16 | 44% |
| Feb 27, 2024 | Needham | reiterate | Buy → Buy | $8 | 50% |
| Nov 13, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $22 | 44% |
| Nov 7, 2023 | Needham | maintain | Buy → Buy | $8 | 50% |
| Oct 2, 2023 | Needham | reiterate | Buy → Buy | $9 | 50% |
| Aug 28, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $22 | 44% |
| Aug 2, 2023 | Needham | maintain | Buy → Buy | $9 | 50% |
No cross-platform signals in the last 90 days